INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Audited Financial Results For The Quarter And Year Ended 31St March, 2024
this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia: 1. approved the audited Financial Statements for the year ended 31st Marc,2024. 2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24 Details are given in the annexures. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Audited Results For The Year Ended 31St March, 2024 And Dividend If Any For The Year 2023-2024
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday, 17th May, 2024 inter alia- a) to consider and approve the audited financial results for the quarter/year ended 31st March, 2024, b) to consider and recommend dividend, if any, on equity shares of the Company for the Financial year 2023-24. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Further to our letter dated 22nd March, 2024, enclosing the Postal Ballot Notice dated 7th March, 2024, for seeking approval of the Members of the Company, for the below mentioned resolutions: 1. Appointment of Mr. Sandip Somany (DIN 00053597) as an Independent Directors; and 2. Appointment of Mr. Tejpreet Singh Chopra (DIN 00317683) as an Independent Director. the remote evoting concluded on 24th April, 2024 at 5 pm. Accordingly, enclosed please find Voting Results along with Scrutinizer''s Report dated 25th April, 2024. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
The Company has received intimation from shareholders on 22nd April, 2024, regarding loss of share certificates, as per details given below: 1. Surinder Kumar Chachra Jt. Santosh Kumari, Folio No. 277, 1000 shares, Certificate Nos/ 2239 - 2248, Distinctive Numbers - 41403993 - 41404992 2. Chhaya Dinesh Shah, Folio No. 24898, 100 shares - Certificate Number - 23077, Dist. Number 69727501 - 69727600 1000 shares - Certificate Number 33262 - 33271, Dist. Numbers 70746001 - 70747000 100 share - Certificate Number 41516, Dist. Numbers 71571401 - 71571500 400 shares - certificate number 46867 - 46870, Distinctive number 77840201 - 77840600. 100 shares - certificate number 128443, distinctive number 80997801 - 80887900 200 shares - certificate numbers 128445 - 128446, distinctive number 80998001 - 80998200 200 shares - certificate number 128452 - 128453, distinctive 80998701 - 80998900 100 shares - certificate number 135017, distinctive number 82288301 - 82288400 This is for your information
Bulk deals: Quant Small Cap Fund picks up stake in Indraprastha Medical
Indraprastha Medical Corporation is a joint venture between Apollo Hospitals and the Delhi Government INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate For The Year Ended 31St March, 2024
Enclosed please find a copy of the certificate from a practicing Company Secretary Certifying that all certificates have been issued, for the financial year ended 31st march, 2024, within 30 days of the date of lodgment for transfer, sub-division, consolidation, etc. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Credit Rating
We wish to inform that ICRA Limited has reaffirmed: a) long-term credit rating of [ICRA]AA (pronounced ICRA Double A) and short-term rating of [ICRA]A1+(pounced ICRA A one Plus) for Rs. 62.50 crore bank facilities; b) short-term credit rating of [ICRA]A1+ (pounced ICRA A one Plus) for Rs 40.00 Crore Commercial Paper to the Company. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate For The Year Ended On 31St March,2024.
Enclosed please find the compliance certificate for the period 1st April, 2023 to 31st March, 2024. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Enclosed please find herewith a Certificate dated 4th April, 2024, issued by M/s. Link Intime India Private Limited, Registrar & share Transfer Agent of the Company, for the quarter ended 31st March,2024. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Clarification On Movement In Share Price
We are of receipt of your email dated 5th April, 2024 seeking our clarification on increase in movement in price of shares of the Company across the exchanges. The detailed clarification enclosed herewith.